APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 29 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $250,000 | -94.0% | 165,000 | -95.2% | 0.02% | -94.1% |
| Q3 2021 | $4,192,000 | -48.5% | 3,418,000 | -22.6% | 0.25% | -52.0% |
| Q2 2021 | $8,147,000 | +286.8% | 4,418,000 | +194.5% | 0.53% | +246.7% |
| Q1 2021 | $2,106,000 | -16.3% | 1,500,000 | 0.0% | 0.15% | -15.6% |
| Q4 2020 | $2,516,000 | +132.3% | 1,500,000 | +50.0% | 0.18% | +93.5% |
| Q3 2020 | $1,083,000 | – | 1,000,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 15,000,000 | $35,954,355 | 1.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $28,207,024 | 0.34% |
| LINDEN ADVISORS LP | 10,000,000 | $23,952,985 | 0.25% |
| Verition Fund Management LLC | 4,796 | $11,487,633 | 0.15% |
| LORD, ABBETT & CO. LLC | 11,712,000 | $28,044 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,267,000 | $3,044,070 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 14,242,000 | $34,113 | 0.04% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $717,076 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $11,995,383 | 0.01% |
| Citadel Advisors | 11,500,000 | $27,556,934 | 0.01% |